Better Therapeutics (BTTX) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock BTTX vs. UPHL, ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, and NTRAShould you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), and Natera (NTRA). These companies are all part of the "healthcare" industry. Better Therapeutics vs. Its Competitors UpHealth Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation. Do institutionals and insiders believe in BTTX or UPHL? 34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by company insiders. Comparatively, 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, BTTX or UPHL? Better Therapeutics has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, UpHealth has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Does the media prefer BTTX or UPHL? In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score. Company Overall Sentiment Better Therapeutics Neutral UpHealth Neutral Is BTTX or UPHL more profitable? Company Net Margins Return on Equity Return on Assets Better TherapeuticsN/A N/A N/A UpHealth N/A N/A N/A Which has better earnings & valuation, BTTX or UPHL? Better Therapeutics has higher earnings, but lower revenue than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBetter TherapeuticsN/AN/A-$39.76MN/AN/AUpHealth$130M0.00-$56.42M-$1.350.00 Does the MarketBeat Community prefer BTTX or UPHL? Better Therapeutics received 5 more outperform votes than UpHealth when rated by MarketBeat users. CompanyUnderperformOutperformBetter TherapeuticsOutperform Votes541.67% Underperform Votes758.33% UpHealthN/AN/A SummaryBetter Therapeutics beats UpHealth on 4 of the 6 factors compared between the two stocks. Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTTX vs. The Competition Export to ExcelMetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$5K$838.67M$5.57B$8.50BDividend YieldN/A2.29%5.27%4.17%P/E RatioN/A55.3326.7519.66Price / SalesN/A8.77403.98152.07Price / CashN/A26.1438.2534.64Price / BookN/A3.546.964.59Net Income-$39.76M-$3.48M$3.23B$248.23M Better Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTTXBetter TherapeuticsN/AN/AN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-100.0%$4K$130M0.001,750ACONWAclarionN/A$0.03-0.3%N/A-7.7%$0.00$54.60K0.007Gap DownAONCAmerican Oncology NetworkN/A$8.45+1.8%N/A+794.3%$0.00$1.34B0.001,520High Trading VolumeDHACWDigital Health AcquisitionN/A$0.05flatN/A-76.3%$0.00N/A0.00N/ALFMDPLifeMDN/A$24.28+1.2%N/A+3.8%$0.00$234.01M0.00230News CoverageShort Interest ↓High Trading VolumeOTRKPOntrakN/A$0.22-5.6%N/A-28.5%$0.00$10.84M0.00250Gap UpPIIIWP3 Health PartnersN/A$0.01-2.5%N/A-86.6%$0.00$1.49B0.00500Gap DownTALKWTalkspaceN/A$0.10-6.3%N/A-40.1%$0.00$194.36M0.00500Short Interest ↑TOIIWOncology InstituteN/A$0.07+1.9%N/A+187.3%$0.00$403.15M0.00660Positive NewsShort Interest ↑Gap DownNTRANatera1.851 of 5 stars$163.91+2.3%$184.63+12.6%+50.0%$22.63B$1.83B-94.153,020Positive NewsInsider Trade Related Companies and Tools Related Companies UPHL Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTTX) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
